Enrolling

A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight

W8M-MC-LAA1 -

The main purpose of this study, performed under the master protocol W8M-MC-CWMM (NCT06143956), is to investigate weight management efficacy and safety with LY3841136 compared with placebo in adult participants with obesity or overweight.

Enter your city or zip code to find the nearest site

See if You May Qualify

Answer a few questions to see if you meet key criteria for this study.

Trial Summary

Age Range
18 - 75 years
Conditions the trial is for
Obesity, Overweight
What the trial is testing?
LY3841136
Could I receive a Placebo?
Yes
Enrollment Goal
225
Trial Dates
Feb 5, 2024 - Sep 2025
How long will I be in the trial?
The study will last about 64 weeks and may include up to 13 visits.
Trial Phase
II

Key Requirements

Clinical trials have inclusion and exclusion requirements to determine which individuals qualify for participation. Listed below are key requirements for this clinical trial, but there may be additional requirements to qualify.

Participants Must:

  • Be 18 or the legal age of consent in the jurisdiction in which the study is taking place to 75 years of age inclusive, at the time of signing the informed consent

  • Have criteria met in the master study

Participants Must Not:

  • Have Diabetes

  • Participants must not have pancreatitis, recent heart attack, stroke, or heart failure

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.

Clinical Trial Resources